Fox Chase Cancer Center, Sylvester Comprehensive Cancer Center, and Pfizer’s Institute of Translational Equitable Medicine formed a collaboration to launch a cancer genomics study to characterize novel genetic, molecular, and social determinants of cancer across populations of African ancestry.
To access this subscriber-only content please log in or renew your subscription.
Looking for IP Login? Our IP Login system is now automatic. If your institution has a site license, please log in from on site or via your VPN to access this content.
Login Subscribe
Looking for IP Login? Our IP Login system is now automatic. If your institution has a site license, please log in from on site or via your VPN to access this content.
Login Subscribe